Thu, 28 May 2015 20:48:14 GMT ~ Five Prime Therapeutics to Present at the Jefferies Healthcare Conference
[at noodls] - SOUTH SAN FRANCISCO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel ...
Thu, 28 May 2015 20:05:00 GMT ~ Five Prime Therapeutics to Present at the Jefferies Healthcare Conference
[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif. -- Five Prime Therapeutics, Inc. (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory ...
Tue, 26 May 2015 20:29:08 GMT ~ bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
[at noodls] - CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- bluebird bio, Inc. (Nasdaq:BLUE) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that they have entered ...
Link: http://www.otcmarkets.com/stock/FPRX/company-info Ticker: $FPRX OTC Market Place: Not Available CIK code: not found Company name: Five Prime Therapeutics, Inc. Incorporated In:
Business Description:
$FPRX share structure
## source: otcmarkets.com
Market Value: Not Available Shares Outstanding: Not Available Float: Not Available Authorized Shares: Not Available Par Value: Not Available